Results 11 to 20 of about 14,446 (212)
Streptokinase‐Induced Serum Sickness: A Case Report [PDF]
ABSTRACT Serum sickness is rare; however, there is a significant hypersensitivity reaction to streptokinase used in different cardiac problems. Treatment often involves discontinuing the offending agent and administering corticosteroids. This case underscores the complexities of managing prosthetic valve thrombosis and highlights the importance of ...
Bibek Shrestha+3 more
wiley +2 more sources
An Insight Into the Phytochemical Composition, Cardioprotective, and Antioxidant Characteristics of Small Knotweed (Polygonum plebeium R. Br.) Extract and Its Derived Fractions [PDF]
Polygonum plebeium, known as small knotweed, has been traditionally used to treat various ailments and is now gaining attention for its cardioprotective effects. Research indicates that the chloroform fraction (Pp.CF) of this plant significantly reduces biomarkers for myocardial infarction and exhibits antihyperlipidemic, membrane stabilizing, and ...
Muhammad Ibrar+9 more
wiley +2 more sources
Stent Crumpling as a Complication of Percutaneous Coronary Intervention, a Case Report and Literature Review [PDF]
The graphical description of stent crumpling and its management. ABSTRACT Stent crumpling is a rare but potentially life‐threatening complication of percutaneous coronary intervention (PCI). This report highlights a case of stent crumpling during a PCI procedure, its management, and the importance of advanced imaging techniques in diagnosing and ...
Maryam Mehrpooya+3 more
wiley +2 more sources
Streptokinase and Myocardial Infarction [PDF]
The results of several multicenter studies on the treatment of acute myocardial infarction with streptokinase are now in. Although the results are variable and, when all of the trials are considered, the impact on overall mortality is rather small, the report appearing in today's Journal suggests that a subgroup of "medium-risk" patients benefit from ...
Jay M. Sullivan
openalex +5 more sources
Streptokinase is an enzyme that can break down the blood clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism.
Armi M. Chaudhari+5 more
doaj +1 more source
PLASMINOGEN ACTIVATION BY LOW MOLECULAR WEIGHT STREPTOKINASE AND FIBRIN EFFECT [PDF]
The purpose is to study the plasminogen-activating activity of 36 kDa-streptokinase fragment, influences of desAB-fibrin on this process and low molecular weight streptokinase on plasmin catalytic properties as well. The 36 kDa-fragment lacking the 63
E. I. Yusova
doaj +1 more source
Early administration of thrombolytic agents is standard for patients presenting with acute myocardial infarction (MI). Also, prolonged QT intervals indicate a higher risk for sudden death in patients with MI.
Reza Ghasemi+3 more
doaj +1 more source
Early administration of thrombolytic agents is the standard treatment and crucial for the outcome for patients presenting with acute myocardial infarction (MI). This study was conducted to evaluate the door to needle time of streptokinase administration
Reza Ghasemi+3 more
doaj +1 more source
Context Parapneumonic effusion and empyema are commonly encountered by the pulmonologist. The decision regarding management is still challenging.
Mervat A Abou Ismail+3 more
doaj +1 more source
Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic /Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study [PDF]
Background: SK, a heterogeneous PA protein from groups A, C, and G streptococci (GAS, GCS, GGS, respectively) contains three structural domains (SKα, SKβ, and SK).
Maryam Rafipour+4 more
doaj +1 more source